It was reported that a patient experienced facial edema, conjunctivitis and dyspnea while performing therapy for the first time using a polyflux 140h.
The incident occurred five minutes into treatment.
Treatment was immediately terminated and the patient was treated with 200 mg of prednisolone, 1 amp of tavergil ("volume intravenous").
The patient was hospitalized in the intensive care unit.
At the time of this report, the patient outcome was reported as "stable".
No additional information is available.
|